Gastric Motility Disorder Drug Market
According to Intent Market Research, the Gastric Motility Disorder Drug Market is expected to grow from USD 55.4 Billion in 2024-e at a CAGR of 6.1% to touch USD 78.9 Billion by 2030. The Gastric Motility Disorder Drug Market is dominated by key players such as, AbbVie Inc., Takeda Pharmaceuticals, Bayer AG, GlaxoSmithKline (GSK), Novartis International AG, and Pfizer Inc..